AAAAAA
Results:
1-12
|
Results: 12
Authors:
TEELING JL
DEGROOT ER
EERENBERG AJM
BLEEKER WK
VANMIERLO G
AARDEN LA
HACK CE
Citation: Jl. Teeling et al., HUMAN INTRAVENOUS IMMUNOGLOBULIN (IVIG) PREPARATIONS DEGRANULATE HUMAN NEUTROPHILS IN-VITRO, Clinical and experimental immunology, 114(2), 1998, pp. 264-270
Authors:
MINNEMA MC
PAJKRT D
WUILLEMIN WA
ROEM D
BLEEKER WK
LEVI M
VANDEVENTER SJH
HACK CE
TENCATE H
Citation: Mc. Minnema et al., ACTIVATION OF CLOTTING FACTOR-XI WITHOUT DETECTABLE CONTACT ACTIVATION IN EXPERIMENTAL HUMAN ENDOTOXEMIA, Blood, 92(9), 1998, pp. 3294-3301
Authors:
VANWAGENSVELD BA
SCHEEPERS JJG
VANGULIK TM
FREDERIKS WN
BLEEKER WK
OBERTOP H
GOUMA DJ
Citation: Ba. Vanwagensveld et al., ALPHA-GLUTATHIONE-S-TRANSFERASE AS NOVEL PARAMETER FOR HEPATOCELLULARDAMAGE IN THE ISOLATED-PERFUSED RAT-LIVER, Transplantation proceedings, 29(8), 1997, pp. 3449-3451
Authors:
WUILLEMIN WA
HACK CE
BLEEKER WK
BIEMOND BJ
LEVI M
TENCATE H
Citation: Wa. Wuillemin et al., INACTIVATION OF FACTOR-XIA IN-VIVO - STUDIES IN CHIMPANZEES AND IN HUMANS, Thrombosis and haemostasis, 76(4), 1996, pp. 549-555
Authors:
LANGERMANS JAM
VANVURENVANDERHULST MEB
BLEEKER WK
Citation: Jam. Langermans et al., SAFETY EVALUATION OF A POLYMERIZED HEMOGLOBIN SOLUTION IN A MURINE INFECTION MODEL, The Journal of laboratory and clinical medicine, 127(5), 1996, pp. 428-434
Authors:
WUILLEMIN WA
BLEEKER WK
AGTERBERG J
RIGTER G
TENCATE H
HACK CE
Citation: Wa. Wuillemin et al., CLEARANCE OF HUMAN FACTOR XIA-INHIBITOR COMPLEXES IN RATS, British Journal of Haematology, 93(4), 1996, pp. 950-954
Authors:
BLEEKER WK
ZAPPEIJ LM
DENBOER PJ
AGTERBERG JA
RIGTER GMM
BAKKER JC
Citation: Wk. Bleeker et al., EVALUATION OF THE IMMUNOGENICITY OF POLYMERIZED HEMOGLOBIN-SOLUTIONS IN A RABBIT MODEL, Artificial cells, blood substitutes, and immobilization biotechnology, 23(4), 1995, pp. 461-468
INACTIVATION OF HUMAN FACTOR-XLA AND CLEARANCE OF XLA-INHIBITOR COMPLEXES IN-VIVO IN A PRIMATE MODEL
Authors:
WUILLEMIN WA
HACK CE
AGTERBERG J
RIGTER G
BLEEKER WK
TENCATE H
Citation: Wa. Wuillemin et al., INACTIVATION OF HUMAN FACTOR-XLA AND CLEARANCE OF XLA-INHIBITOR COMPLEXES IN-VIVO IN A PRIMATE MODEL, Thrombosis and haemostasis, 73(6), 1995, pp. 1409-1409
Authors:
LANGERMANS JAM
BLEEKER WK
Citation: Jam. Langermans et Wk. Bleeker, HEMOGLOBIN-BASED BLOOD SUBSTITUTES AND INFECTION, Lancet, 345(8953), 1995, pp. 863-864
Authors:
BAKKER JC
BLEEKER WK
DENBOER PJ
BIESSELS PTM
AGTERBERG J
RIGTER G
HOLTHUIS JCM
MERTENS K
Citation: Jc. Bakker et al., PREVENTION OF SIDE-EFFECTS BY HEMOGLOBIN-SOLUTIONS THE SELECTION OF OPTIMAL TEST MODELS, ESPECIALLY CONCERNING THROMBOGENICITY, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 577-585
Authors:
BLEEKER WK
DEGROOT EM
DENBOER PJ
BIESSELS PTM
AARDEN LA
BAKKER JC
Citation: Wk. Bleeker et al., MEASUREMENT OF INTERLEUKIN-6 PRODUCTION BY MONOCYTES FOR IN-VITRO SAFETY TESTING OF HEMOGLOBIN-SOLUTIONS, Artificial cells, blood substitutes, and immobilization biotechnology, 22(3), 1994, pp. 835-840
Authors:
BAKKER JC
BLEEKER WK
Citation: Jc. Bakker et Wk. Bleeker, BLOOD SUBSTITUTES BASED ON MODIFIED HEMOGLOBIN, Vox sanguinis, 67, 1994, pp. 139-142
Risultati:
1-12
|